Caris Life Value At Risk
| CAI Stock | | | USD 19.24 -0.02 -0.10% |
The Value At Risk profile for Caris Life Sciences is based on historical price and volume observations. Related screening structures are referenced through
Equity Screeners. Caris Life has a market cap of 5.2 B, operating margin of 30.19%, current ratio of 0.45. Portfolio-level context is available through
Trending Equities. Caris Life Sciences can be included in a portfolio to evaluate diversification impact. All values are based on available data and provided as reference information. Broader economic conditions can influence Caris Life Sciences's company valuation — related indicators include
signals in nation.
Caris Life Sciences has current Value At Risk of
-6.33. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -6.33 | |
| ER[a] | = | Expected return on investing in Caris Life |
| STD | = | Standard Deviation of Caris Life |
| N | = | Number of points for the period |
| Z-SCORE | = | Number of standard deviations above or below the mean |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Caris Life Sciences is rated
below average for value at risk among direct rivals. It is currently under evaluation for maximum drawdown among direct rivals .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Caris Life to Peers
Other Technical Indicators